105 related articles for article (PubMed ID: 2667306)
1. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency.
Denys BG; Reddy PS; Uretsky BF
Am J Cardiol; 1989 Aug; 64(5):405-6. PubMed ID: 2667306
[No Abstract] [Full Text] [Related]
2. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent.
Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM
N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042
[TBL] [Abstract][Full Text] [Related]
3. The use of ionic and nonionic contrast agents and the effects of hydration in the post cardiac transplant patient with moderate renal insufficiency.
Denys BG; Reddy PS; Urestsky BF
Angiology; 1991 Mar; 42(3):218-23. PubMed ID: 2018243
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography.
Taliercio CP; Vlietstra RE; Ilstrup DM; Burnett JC; Menke KK; Stensrud SL; Holmes DR
J Am Coll Cardiol; 1991 Feb; 17(2):384-90. PubMed ID: 1991894
[TBL] [Abstract][Full Text] [Related]
5. Renal toxicity of contrast agents: iopamidol, iothalamate, and diatrizoate.
Gale ME; Robbins AH; Hamburger RJ; Widrich WC
AJR Am J Roentgenol; 1984 Feb; 142(2):333-5. PubMed ID: 6607603
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the toxicity of the radiocontrast agents, iopamidol and diatrizoate, to rabbit renal proximal tubule cells in vitro.
Messana JM; Cieslinski DA; Nguyen VD; Humes HD
J Pharmacol Exp Ther; 1988 Mar; 244(3):1139-44. PubMed ID: 3252027
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine nephropathy after heart and heart-lung transplantation.
Goldstein J; Thoua Y; Wellens F; Leclerc JL; Vanherweghem JL; Vereerstraeten P; Primo G; Toussaint C
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():973-81. PubMed ID: 3921960
[TBL] [Abstract][Full Text] [Related]
8. Tubular nephrotoxicity after intravenous urography with ionic high-osmolal and nonionic low-osmolal contrast media in patients with chronic renal insufficiency.
Cavaliere G; Arrigo G; D'Amico G; Bernasconi P; Schiavina G; Dellafiore L; Vergnaghi D
Nephron; 1987; 46(2):128-33. PubMed ID: 2885767
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cardiovascular and renal toxicity after cardiac catheterization using a nonionic versus ionic radiographic contrast agent.
Harding MB; Davidson CJ; Pieper KS; Hlatky M; Schwab SJ; Morris KG; Hermiller JB; Bashore TM
Am J Cardiol; 1991 Oct; 68(10):1117-9. PubMed ID: 1927936
[No Abstract] [Full Text] [Related]
10. The spectrum of ciclosporin nephrotoxicity.
Puschett JB; Greenberg A; Holley J; McCauley J
Am J Nephrol; 1990; 10(4):296-309. PubMed ID: 2240057
[No Abstract] [Full Text] [Related]
11. Cyclosporine nephrotoxicity and the role of cyclosporine in living-related donor transplantation.
Paller MS
Am J Kidney Dis; 1990 Nov; 16(5):414-6. PubMed ID: 2239930
[No Abstract] [Full Text] [Related]
12. Effects of nonionic versus ionic contrast media on complications of percutaneous transluminal coronary angioplasty.
Lembo NJ; King SB; Roubin GS; Black AJ; Douglas JS
Am J Cardiol; 1991 May; 67(13):1046-50. PubMed ID: 2024591
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up.
Greenberg A; Thompson ME; Griffith BJ; Hardesty RL; Kormos RL; el-Shahawy MA; Janosky JE; Puschett JB
Transplantation; 1990 Oct; 50(4):589-93. PubMed ID: 2219280
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine nephrotoxicity and cyclosporine--digoxin interaction prior to heart transplantation.
Dorian P; Cardella C; Strauss M; David T; East S; Ogilvie R
Transplant Proc; 1987 Feb; 19(1 Pt 2):1825-7. PubMed ID: 3274430
[No Abstract] [Full Text] [Related]
15. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Kolkin S; Nahman NS; Mendell JR
Neurology; 1987 Jan; 37(1):147-9. PubMed ID: 3796829
[TBL] [Abstract][Full Text] [Related]
16. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
[TBL] [Abstract][Full Text] [Related]
17. Chronic irreversible nephrotoxicity from cyclosporin A.
Rao KV; Crosson JT; Kjellstrand CM
Nephron; 1985; 41(1):75-7. PubMed ID: 3897887
[TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.
Katholi RE; Taylor GJ; Woods WT; Womack KA; Katholi CR; McCann WP; Moses HW; Dove JT; Mikell FL; Woodruff RC
Radiology; 1993 Jan; 186(1):183-7. PubMed ID: 8416561
[TBL] [Abstract][Full Text] [Related]
19. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
[No Abstract] [Full Text] [Related]
20. Cyclosporine nephrotoxicity.
Barton CH; Vaziri ND
Int J Artif Organs; 1985 Nov; 8(6):291-6. PubMed ID: 4077286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
